Table 1.
Baseline Characteristics of COVID-19-Positive Patients, by Race/Ethnicity and Hospitalization Status
| Demographics and baseline comorbidities | All (N = 62,339) | White | Black | Hispanic | |||
|---|---|---|---|---|---|---|---|
| Hospitalized (N = 4526) | Non-hospitalized (N = 24,805) | Hospitalized (N = 3431) | Non-hospitalized (N = 9207) | Hospitalized (N = 5149) | Non-hospitalized (N = 15,221) | ||
| Demographics | |||||||
| Age categories (%) | |||||||
| 20 to <40 years | 22.9 | 11.9 | 22.0 | 14.3 | 25.4 | 19.9 | 29.1 |
| 40 to <55 years | 23.7 | 12.2 | 22.6 | 18.0 | 30.0 | 18.0 | 28.5 |
| 55 to <65 years | 21.6 | 17.8 | 22.1 | 25.8 | 23.6 | 19.4 | 20.5 |
| 65 to <75 years | 18.0 | 25.2 | 19.6 | 22.4 | 13.8 | 21.0 | 13.5 |
| 75 to <85 years | 10.2 | 20.4 | 10.5 | 14.5 | 5.9 | 15.2 | 6.5 |
| 85+ years | 3.6 | 12.4 | 3.2 | 4.9 | 1.3 | 6.6 | 1.9 |
| Race/ethnicity (%) | |||||||
| Non-Hispanic white | 47.1 | – | – | – | – | – | – |
| Non-Hispanic black | 20.3 | – | – | – | – | – | – |
| Hispanic | 32.7 | – | – | – | – | – | – |
| Sex (%) | |||||||
| Female | 59.7 | 48.5 | 55.0 | 58.0 | 67.9 | 57.6 | 66.9 |
| Male | 40.3 | 51.5 | 45.0 | 42.0 | 32.2 | 42.4 | 33.1 |
| Other/missing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Index date (%) | |||||||
| March 2020–June 2020 | 29.2 | 31.9 | 25.1 | 42.0 | 33.0 | 39.8 | 26.5 |
| July 2020–October 2020 | 14.9 | 11.7 | 18.0 | 7.0 | 14.4 | 8.6 | 15.0 |
| November 2020–February 2021 | 34.9 | 36.5 | 36.9 | 28.2 | 29.9 | 31.9 | 36.7 |
| March 2021–June 2021 | 16.4 | 15.5 | 15.1 | 18.0 | 17.3 | 16.4 | 18.0 |
| July 2021–October 2021 | 4.6 | 4.4 | 5.0 | 4.8 | 5.6 | 3.3 | 3.8 |
| Comorbidities, (%) | |||||||
| Alcohol abuse | 2.0 | 3.5 | 0.8 | 4.7 | 1.6 | 5.1 | 1.9 |
| Anemia | 10.8 | 18.4 | 5.8 | 28.0 | 12.2 | 20.8 | 8.5 |
| Arrythmia | 12.9 | 35.4 | 11.1 | 24.3 | 8.1 | 21.2 | 6.7 |
| Asthma | 10.2 | 8.7 | 6.1 | 16.4 | 11.3 | 17.2 | 13.0 |
| Cancer | 9.4 | 15.5 | 9.3 | 12.0 | 8.1 | 10.4 | 7.7 |
| Chronic kidney disease | 9.6 | 20.7 | 4.2 | 31.7 | 8.7 | 22.9 | 6.1 |
| Chronic pulmonary disorders | 15.1 | 20.2 | 11.0 | 25.6 | 14.5 | 23.3 | 15.4 |
| Cirrhosis | 1.2 | 2.1 | 0.7 | 1.9 | 0.6 | 3.3 | 1.3 |
| Coagulopathy | 4.7 | 16.0 | 2.6 | 11.1 | 2.4 | 10.8 | 2.6 |
| Congestive heart failure | 7.9 | 18.1 | 4.2 | 22.4 | 6.6 | 17.4 | 5.1 |
| COPD | 4.2 | 10.4 | 3.2 | 10.6 | 2.7 | 8.1 | 2.2 |
| Coronary artery disease | 12.3 | 27.4 | 11.3 | 20.8 | 7.1 | 21.4 | 7.6 |
| Dementia | 2.1 | 8.3 | 0.7 | 5.7 | 0.7 | 5.9 | 1.1 |
| Diabetes type 1 | 1.0 | 1.3 | 0.7 | 2.0 | 0.7 | 2.1 | 0.8 |
| Diabetes type 2 | 18.0 | 23.2 | 9.4 | 40.0 | 19.0 | 38.0 | 18.0 |
| End-stage renal disease on dialysis | 3.0 | 3.9 | 0.7 | 12.7 | 3.4 | 8.7 | 2.0 |
| Hemiplegia | 0.9 | 1.9 | 0.4 | 3.6 | 0.6 | 1.8 | 0.5 |
| HIV | 1.6 | 0.6 | 0.7 | 3.6 | 3.0 | 2.0 | 2.1 |
| Hypertension | 37.3 | 52.9 | 29.5 | 63.8 | 40.4 | 54.5 | 31.8 |
| Hypertension and type 1 or 2 diabetes diagnosis | 14.6 | 20.8 | 7.4 | 36.0 | 15.1 | 32.5 | 13.5 |
| Inflammatory bowel disorder | 1.2 | 1.9 | 1.7 | 1.3 | 0.5 | 0.8 | 0.7 |
| Lupus or systemic lupus erythematosus | 0.8 | 0.5 | 0.3 | 1.9 | 1.2 | 1.3 | 0.9 |
| Mental health disorders | 8.9 | 15.9 | 5.4 | 14.7 | 6.6 | 16.8 | 9.9 |
| Multiple sclerosis | 0.6 | 1.0 | 0.6 | 0.6 | 0.8 | 0.4 | 0.4 |
| Parkinson’s disease | 0.5 | 1.9 | 0.5 | 0.8 | 0.2 | 1.0 | 0.3 |
| Peripheral vascular disorders | 6.1 | 12.9 | 4.2 | 13.8 | 4.6 | 12.4 | 4.2 |
| Pregnant | 3.3 | 6.0 | 1.6 | 4.0 | 2.3 | 9.3 | 3.6 |
| Pulmonary circulation disorder | 1.3 | 3.2 | 0.8 | 4.1 | 1.4 | 2.0 | 0.7 |
| Rheumatoid arthritis | 1.5 | 1.8 | 1.2 | 2.5 | 1.3 | 2.0 | 1.8 |
| Seizure/epilepsy | 1.6 | 3.8 | 1.0 | 3.6 | 1.3 | 3.2 | 1.2 |
| Severe obesity (BMI≥40 kg/m2) | 6.6 | 7.4 | 3.6 | 13.6 | 9.1 | 9.2 | 7.3 |
| Weight Loss | 2.8 | 7.7 | 1.4 | 7.8 | 2.2 | 5.9 | 1.7 |